vermicon AG provides innovative technologies, specific microbiological expertise and cultivation-independent methods for the direct analysis, quantification and visualization of microorganisms. By using individually adapted, alternative microbiological solutions, vermicon supports pharmaceutical companies and CDMOs active in the development of microbiome-based therapeutics. The company services include solutions for all stages of the production chain, from research and development to the final product, uncovering mechanisms and correlations that cannot be determined by using sequence data or conventional cultivation methods only.
Intertek’s GLP/GCP/GMP compliant laboratories provide support to clients focused on the development of pharmaceuticals and biologics. Our biomarker services provide both fit-for-purpose validations in support of exploratory biomarkers and full validation for biomarkers used as a companion diagnostic. Drug efficacy and safety profiling is performed using an array of platforms including ultra-sensitive ELISA, flow cytometry, cell-based assays and ECL multiplex platforms as well as provision of immunogenicity bioanalysis for pre-clinical and clinical studies.
VCLS is a global product development consultancy, which guides Biotechnology, Medtech, and Pharmaceutical manufacturers throughout product development and commercialization. From discovery to patients, VCLS assists innovators to design product development strategies that optimize clinical development to drive commercial success, through an understanding of both regulators and payers.
VCLS’s team of HealthTech product specialists seamlessly complement innovative life sciences companies’ resources with strategic advice and cross-functional operational capabilities. The firm offers integrated solutions to development planning, manufacturing, quality and controls, nonclinical and clinical testing, safety monitoring, and interactions with regulators and payers. With offices in Cambridge, Somerville (MA & NJ, USA), London (UK), Paris and Rennes (France), Lausanne (Switzerland), Copenhagen (Denmark) and Bangalore (India). VCLS serves a broad range of developers and investors.
For more information, visit www.voisinconsulting.com
Biose industry is the only CDMO for Live Biotherapeutics that can take your project from early process development right through the clinic and into commercial production of your Drug Substance & Drug Product. Established for over 70 years as a GMP pharmaceutical company we have biggest fermentation volumes of any LBP CDMO and we look forward to supporting you with your therapeutic journey.
